Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Depreciation & Amortization (CF) (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Depreciation & Amortization (CF) for 11 consecutive years, with $204482.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 10.23% to $204482.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $842780.0, a 6.91% decrease, with the full-year FY2024 number at $888473.0, up 2.08% from a year prior.
  • Depreciation & Amortization (CF) was $204482.0 for Q3 2025 at KORU Medical Systems, down from $209487.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $231370.0 in Q1 2024 to a low of $109252.0 in Q1 2022.
  • A 5-year average of $181076.6 and a median of $209487.0 in 2025 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 95.07% in 2023, then dropped 10.23% in 2025.
  • KORU Medical Systems' Depreciation & Amortization (CF) stood at $113308.0 in 2021, then soared by 65.62% to $187658.0 in 2022, then increased by 21.68% to $228340.0 in 2023, then decreased by 7.4% to $211454.0 in 2024, then dropped by 3.3% to $204482.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Depreciation & Amortization (CF) are $204482.0 (Q3 2025), $209487.0 (Q2 2025), and $217357.0 (Q1 2025).